U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H15NO3
Molecular Weight 197.231
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DESGLYMIDODRINE

SMILES

COC1=CC=C(OC)C(=C1)C(O)CN

InChI

InChIKey=VFRCNXKYZVQYLX-UHFFFAOYSA-N
InChI=1S/C10H15NO3/c1-13-7-3-4-10(14-2)8(5-7)9(12)6-11/h3-5,9,12H,6,11H2,1-2H3

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
7.1 µM [EC50]
85.0 µM [EC50]
1.9 µM [EC50]
PubMed

PubMed

TitleDatePubMed
ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes.
2002 Aug 2
Patents
Name Type Language
DESGLYMIDODRINE
Common Name English
ST-1059
Code English
1-(2',5'-DIMETHOXYPHENYL)-2-AMINOETHANOL
Systematic Name English
MIDODRINE RELATED COMPOUND A
USP-RS  
Common Name English
1-(2,5 DIMETHOXYPHENYL)-2-AMINOETHANOL
Systematic Name English
MIDODRINE RELATED COMPOUND A [USP-RS]
Common Name English
BENZYL ALCOHOL, .ALPHA.-(AMINOMETHYL)-2,5-DIMETHOXY-
Systematic Name English
1-(2,5-DIMETHOXYPHENYL)-2-AMINOETHANOL
Systematic Name English
Code System Code Type Description
PUBCHEM
43260
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY
FDA UNII
S57K35I2FV
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY
RS_ITEM_NUM
1443715
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY
CHEBI
73248
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY
EPA CompTox
DTXSID00957424
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY
CAS
3600-87-1
Created by admin on Sat Dec 16 08:39:32 GMT 2023 , Edited by admin on Sat Dec 16 08:39:32 GMT 2023
PRIMARY